SUPN financials

Supernus Pharmaceuticals (SUPN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

SUPN income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$1.24B$994.00M$262.00M$210.00M1.64
2024$1.19B$957.00M$38.00M$7.00M0.05
2023$1.09B$919.00M-$152.00M-$126.00M-0.92
2022$901.00M$749.00M-$81.00M-$44.00M-0.32

Updated 2026-11-15 15:36 UTC